Description

The Institute of Molecular Bioimaging and Physiology (IBFM) was established on October 12, 2001, combining the activities of: the Institute of Neuroscience and Bioimaging; the Unit of Molecular Physiology and Biotechnology of the previous Institute of Advanced Biomedical Technologies, Milan and of the Centre for the Study of Cerebral Neurophysiology of Genoa. It was later expanded with the establishment of two additional Research Sections in Cefalù (PA) and Germaneto (CZ). Current organization is as follows:
o Main Institute in Segrate (Milano), LITA Building (Interdisciplinary Laboratory of Advanced Technologies);
o Cefalù Unit (Palermo), at Fondazione Istituto G. Giglio di Cefalù, established in 2008;
o Germaneto Section (Catanzaro), at the University Magna Graecia of Catanzaro, established in 2013 by following a reorganization of the Institute of Neurological Sciences.
o Lecco Section at the Lecco Technological Pole, established in November 2017, implementing the resolution of the CNR Board of Directors which on February 26, 2015 approved the constitution
The Institute is part of the Department of Biomedical Sciences.

Main research topics can be organized into four research areas, sharing each the scientific goal and reflecting the geographical organization of the Institute, but open to inter-sections collaborations:
- Molecular Imaging (Segrate)
- Neuroimaging (Section Germaneto)
- Therapeutic techniques and biological effects of radiation (Section Cefalù)

The research approach of IBFM is characterized by:
- High technology, making use of advanced equipment, in particular in the field of Bioimaging, taking advantage from formal agreements with Universities and Medical Institutes of Research
- Multi-disciplinarity: research topics involve several disciplines ranging from medical to technological;
- Inter-disciplinarity: different disciplines are closely integrated through scientific collaborations towards common research goals;
- Connection between basic and clinical/applied research: translational research implying a direct transfer of results from basic to clinical research and vice versa.

These features are made possible by the structure of IBFM, organized in laboratories with diverse scientific and technological expertise and by several formal collaborations and agreements with external Institutions.
Research activities are carried out with a synergistic approach, emphasizing the interactions between laboratories and in collaboration between the different IBFM sections.

Human resources: 32 Researchers/Technologists, 10 technicians, 3 administrative, 10 young researchers and 15 associate researchers, relating to national universities and clinical institutions collaborating with IBFM on specific research projects.


SCIENTIFIC PRODUCTION
The Institute is productive both quantitatively and qualitatively. During the period 2016-2019, 480 papers have been on international PubMed journals (442 with IF). Mean IF was 4.2